三生国健：第三季度净利润同比增长101.41%

Core Viewpoint - Sanofi Guojian (688336.SH) reported strong financial performance for Q3 2025, indicating significant growth in both revenue and net profit [1] Financial Performance - In Q3 2025, the company achieved revenue of 474 million yuan, representing a year-on-year increase of 38.27% [1] - The net profit attributable to shareholders for Q3 2025 was 209 million yuan, showing a remarkable year-on-year growth of 101.41% [1] - For the first three quarters of 2025, the company recorded total revenue of 1.116 billion yuan, which is an 18.80% increase compared to the same period last year [1] - The net profit attributable to shareholders for the first three quarters reached 399 million yuan, reflecting a year-on-year growth of 71.15% [1]